Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
10.3164/jcbn.20-124 47 KasamatsuS.NishimuraA.MoritaM.MatsunagaT.Abdul HamidH.AkaikeT
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
More research into its ability to protect healthy cells is welcome
How Peptides Reduce Inflammation Understanding how peptide therapy for inflammation works requires looking at the biological pathways involved
Low dose (0.1 mg/kg/d) can promote fat breakdown, reduce serum triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C)
